靶向胰岛素样生长因子信号传导：合理的联合策略。 - Suppr

Suppr

超能文献

Targeting insulin-like growth factor signaling: rational combination strategies.

作者信息

Olmos David, Basu Bristi, de Bono Johann S

出版信息

Mol Cancer Ther. 2010 Sep;9(9):2447-9. doi: 10.1158/1535-7163.MCT-10-0719. Epub 2010 Aug 31.

DOI:10.1158/1535-7163.MCT-10-0719

PMID:20807783

Abstract

摘要

相似文献

Targeting insulin-like growth factor signaling: rational combination strategies.

Mol Cancer Ther. 2010 Sep;9(9):2447-9. doi: 10.1158/1535-7163.MCT-10-0719. Epub 2010 Aug 31.

Targeting the insulin growth factor receptor 1.

Hematol Oncol Clin North Am. 2012 Jun;26(3):527-42, vii-viii. doi: 10.1016/j.hoc.2012.01.004. Epub 2012 Feb 28.

Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.

Cancer Res. 2011 Feb 1;71(3):1029-40. doi: 10.1158/0008-5472.CAN-10-2274. Epub 2011 Jan 18.

Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity.

Mol Cancer Ther. 2011 Sep;10(9):1677-85. doi: 10.1158/1535-7163.MCT-11-0281. Epub 2011 Jul 12.

Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response.

Mol Cancer Ther. 2010 Sep;9(9):2593-604. doi: 10.1158/1535-7163.MCT-09-1018. Epub 2010 Aug 17.

Minireview: IGF, Insulin, and Cancer.

Endocrinology. 2011 Jul;152(7):2546-51. doi: 10.1210/en.2011-0231. Epub 2011 May 3.

Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin.

Mol Cancer Ther. 2014 Feb;13(2):399-409. doi: 10.1158/1535-7163.MCT-13-0598. Epub 2013 Dec 2.

Targeting the type I insulin-like growth factor system for breast cancer therapy.

Curr Drug Targets. 2010 Sep;11(9):1121-32. doi: 10.2174/138945010792006816.

Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.

Mol Cell Endocrinol. 2013 Jan 5;365(1):17-24. doi: 10.1016/j.mce.2012.08.021. Epub 2012 Sep 7.

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.

Cancer Lett. 2015 Oct 28;367(2):113-21. doi: 10.1016/j.canlet.2015.07.026. Epub 2015 Jul 29.

引用本文的文献

Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.

PLoS Comput Biol. 2021 Jun 30;17(6):e1009125. doi: 10.1371/journal.pcbi.1009125. eCollection 2021 Jun.

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

J Natl Cancer Inst. 2016 Aug 30;108(12). doi: 10.1093/jnci/djw182. Print 2016 Dec.

Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.

Mol Cell Proteomics. 2016 Sep;15(9):3045-57. doi: 10.1074/mcp.M115.057729. Epub 2016 Jun 30.

Recent developments in receptor tyrosine kinases targeted anticancer therapy.

Vet World. 2016 Jan;9(1):80-90. doi: 10.14202/vetworld.2016.80-90. Epub 2016 Jan 29.

Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

World J Gastroenterol. 2015 Feb 28;21(8):2303-14. doi: 10.3748/wjg.v21.i8.2303.

Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.

Oncogene. 2014 Dec 11;33(50):5697-705. doi: 10.1038/onc.2013.509. Epub 2013 Dec 2.

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.

BMC Cancer. 2013 Nov 4;13:521. doi: 10.1186/1471-2407-13-521.

Impact of targeting insulin-like growth factor signaling in head and neck cancers.

Growth Horm IGF Res. 2013 Oct;23(5):135-40. doi: 10.1016/j.ghir.2013.06.001. Epub 2013 Jun 29.

Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1267-76. doi: 10.1073/pnas.1105034109. Epub 2012 Apr 23.

Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?

Invest New Drugs. 2012 Dec;30(6):2433-42. doi: 10.1007/s10637-012-9811-0. Epub 2012 Mar 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验